Molecular imaging developer PEM Technologies has received Food and Drug Administration 510(k) clearance for a device that applies compression during scintigraphic breast imaging. The device is intended to support, position, and immobilize the breast during imaging examinations with injectable agents, according to the Bethesda, MD-based manufacturer. The device is currently being employed at Harbor-UCLA Medical Center in a clinical trial assessing the sensitivity of breast imaging agents.
PEM Technologies sold its first full-field research PET scanner this past quarter, and is in discussions with several major medical device companies concerning strategic alliances for the development and marketing of PET-based breast imaging systems, according to the vendor.
Other PEM products under development for imaging and minimally invasive surgery include a handheld PET scanner for breast and prostate imaging, and a pathology tool for imaging cancer cells in surgical specimens.
By AuntMinnie.com staff writersFebruary 14, 2001
Copyright © 2001 AuntMinnie.com
